Evidence map›Paper›PMID 17920047›Full record

ArticleBrain research2007

Dilation and degradation of the brain extracellular matrix enhances penetration of infused polymer nanoparticles.

Keith B Neeves, Andrew J Sawyer, Conor P Foley, W Mark Saltzman, William L Olbricht

Abstract readComparative StudyEvaluation Study
In one paragraph

Article in Brain research, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Renal clearable nanocarriers: Overcoming the physiological barriers for precise drug delivery and clearance.Journal of controlled release : official journal of the Controlled Release Society · 2020
    Article
  10. Review
  11. Review
  12. Nanotherapeutic systems for local treatment of brain tumors.Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology · 2018
    Review
  13. Strategies to enhance the distribution of nanotherapeutics in the brain.Journal of controlled release : official journal of the Controlled Release Society · 2017
    Article
  14. Article
  15. Article
  16. Article
  17. Distribution of polymer nanoparticles by convection-enhanced delivery to brain tumors.Journal of controlled release : official journal of the Controlled Release Society · 2016
    Article
  18. Article
  19. Review
  20. Enhanced brain distribution of modified aspartoacylase.Molecular genetics and metabolism · 2014
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Keith B NeevesDepartment of Chemical and Biomolecular Engineering, University of Pennsylvania, Philadelphia, PA 19104, USA.
Andrew J Sawyer
Conor P Foley
W Mark Saltzman
William L Olbricht

Funding

Microfluidic/controlled systems on brain microprobesR01NS045236 · NINDS · YALE UNIVERSITY · PI SALTZMAN, W MARK · 2003 to 2007
$1.3M
NINDS NIH HHS NS-045236NINDS NIH HHS R01 NS045236
6 · The paper itself

Abstract

This study investigates methods of manipulating the brain extracellular matrix (ECM) to enhance the penetration of nanoparticle drug carriers in convection-enhanced delivery (CED). A probe was fabricated with two independent microfluidic channels to infuse, either simultaneously or sequentially, nanoparticles and ECM-modifying agents. Infusions were performed in the striatum of the normal rat brain. Monodisperse polystyrene particles with a diameter of 54 nm were used as a model nanoparticle system. Because the size of these particles is comparable to the effective pore size of the ECM, their transport may be significantly hindered compared with the transport of low molecular weight molecules. To enhance the transport of the infused nanoparticles, we attempted to increase the effective pore size of the ECM by two methods: dilating the extracellular space and degrading selected constituents of the ECM. Two methods of dilating the extracellular space were investigated: co-infusion of nanoparticles and a hyperosmolar solution of mannitol, and pre-infusion of an isotonic buffer solution followed by infusion of nanoparticles. These treatments resulted in an increase in the nanoparticle distribution volume of 51% and 123%, respectively. To degrade hyaluronan, a primary structural component of the brain ECM, a pre-infusion of hyaluronidase (20,000 U/mL) was followed after 30 min by infusion of nanoparticles. This treatment resulted in an increase in the nanoparticle distribution of 64%. Our results suggest that both dilation and enzymatic digestion can be incorporated into CED protocols to enhance nanoparticle penetration.

Indexed as

AnimalsConvectionDilatationDrug Delivery SystemsExtracellular FluidExtracellular MatrixHyaluronoglucosaminidaseMaleMicroelectrodesMolecular WeightNanoparticlesNeostriatumOsmolar ConcentrationPolymersPolystyrenesRatsHyaluronoglucosaminidasePolymersPolystyrenes

Identifiers

PMID17920047
PMCPMC2169304

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.